These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23603900)

  • 1. Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas.
    Duray A; Descamps G; Decaestecker C; Sirtaine N; Gilles A; Khalifé M; Chantrain G; Depuydt CE; Delvenne P; Saussez S
    Oncol Rep; 2013 Jul; 30(1):371-6. PubMed ID: 23603900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
    Rautava J; Kuuskoski J; Syrjänen K; Grenman R; Syrjänen S
    J Clin Virol; 2012 Feb; 53(2):116-20. PubMed ID: 22177275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
    Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M;
    Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
    Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
    Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
    Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
    Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
    Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus and head and neck squamous cell carcinomas in the South-East of France: prevalence, viral expression, and prognostic implications.
    Gavid M; Pillet S; Pozzetto B; Oriol M; Dumollard JM; Timoshenko AP; Martin C; Prades JM
    Acta Otolaryngol; 2013 May; 133(5):538-43. PubMed ID: 23350597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
    Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma.
    Duray A; Descamps G; Decaestecker C; Remmelink M; Sirtaine N; Lechien J; Ernoux-Neufcoeur P; Bletard N; Somja J; Depuydt CE; Delvenne P; Saussez S
    Laryngoscope; 2012 Jul; 122(7):1558-65. PubMed ID: 22532307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous human papillomavirus in head and neck squamous cell carcinomas.
    Lindel K; Helmke B; Simon C; Weber KJ; Debus J; de Villiers EM
    Cancer Invest; 2009 Aug; 27(7):781-7. PubMed ID: 19513898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
    Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
    Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas in northern Spain.
    Rodrigo JP; Hermsen MA; Fresno MF; Brakenhoff RH; García-Velasco F; Snijders PJ; Heideman DA; García-Pedrero JM
    Cancer Epidemiol; 2015 Feb; 39(1):37-41. PubMed ID: 25468644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
    Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
    Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Kiyuna A; Matayoshi S; Uehara T; Agena S; Yamashita Y; Ogawa K; Maeda H; Suzuki M
    Head Neck; 2013 Jun; 35(6):800-8. PubMed ID: 22791649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer.
    Chen AM; Zahra T; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Vaughan AT
    Head Neck; 2013 Nov; 35(11):1652-6. PubMed ID: 23335285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.